244 related articles for article (PubMed ID: 6611543)
21. Spleen lymphocyte populations in patients with Hodgkin's disease--properties of cells with different densities.
Rocha B; Ferreira AA; Munn G; de Sousa M; Freitas AA
Clin Exp Immunol; 1982 May; 48(2):300-6. PubMed ID: 7105487
[TBL] [Abstract][Full Text] [Related]
22. Immunologic parameters in childhood Hodgkin's disease II. T and B lymphocytes in the peripheral blood of normal children and in the spleen and peripheral blood of children with Hodgkin's disease.
de Sousa M; Tan CT; Siegal FP; Filippa DA; Tan R; Good RA
Pediatr Res; 1978 Feb; 12(2):143-7. PubMed ID: 306089
[TBL] [Abstract][Full Text] [Related]
23. Persisting lymphocyte deficiences during remission in Hodgkin's disease.
Björkholm M; Holm G; Mellstedt H
Clin Exp Immunol; 1977 Jun; 28(3):389-93. PubMed ID: 302164
[TBL] [Abstract][Full Text] [Related]
24. Lymphocyte populations of non-scleronodular Hodgkin's disease subtypes in different stages of lymphocyte depletion. An immunophenotypic and quantitative study.
Valente G; Ferrara P; Stramignoni A
Virchows Arch B Cell Pathol Incl Mol Pathol; 1990; 58(4):289-94. PubMed ID: 1970692
[TBL] [Abstract][Full Text] [Related]
25. Increase of peripheral B lymphocytes in Graves' disease.
Mori H; Amino N; Iwatani Y; Kabutomori O; Asari S; Motoi S; Miyai K; Kumahara Y
Clin Exp Immunol; 1980 Oct; 42(1):33-40. PubMed ID: 6970099
[TBL] [Abstract][Full Text] [Related]
26. PHA dose dependent defect in lymphocyte stimulation and E-rosette-forming cells in untreated Hodgkin's disease.
Land JM; Litwin J; Bigel P; Oberling F; Mayer S
Acta Haematol Pol; 1977; 8(2):131-4. PubMed ID: 329629
[TBL] [Abstract][Full Text] [Related]
27. [T- and B-lymphocyte changes in lymphogranulomatosis].
Il'in NV; Vinokurova NA; Gershanovich ML; Letskiĭ VB
Vopr Onkol; 1979; 25(6):19-22. PubMed ID: 380155
[TBL] [Abstract][Full Text] [Related]
28. Stage-dependent reduction in T colony formation in Hodgkin's disease. Coincidence with monocyte synthesis of prostaglandins.
Bockman RS
J Clin Invest; 1980 Sep; 66(3):523-31. PubMed ID: 6967491
[TBL] [Abstract][Full Text] [Related]
29. Effect of thymosin on T-lymphocyte rosette formation in Nigerian patients with different types of cancer.
Olusi SO; Oluwole SF; Odesanmi WO
Afr J Med Med Sci; 1984; 13(3-4):103-9. PubMed ID: 6099969
[TBL] [Abstract][Full Text] [Related]
30. [Immunological data in the clinical evaluation of Hodgkin's diseases].
Burchardt K
Z Gesamte Inn Med; 1981 Nov; 36(21):840. PubMed ID: 6977241
[TBL] [Abstract][Full Text] [Related]
31. [Expression of surface markers of lymphocytes and their relation to suppressor function in lymphogranulomatosis].
Tabagari DZ; Chernovskaia EM; Kadagidze ZG
Eksp Onkol; 1985; 7(2):60-4. PubMed ID: 3159562
[TBL] [Abstract][Full Text] [Related]
32. Human post-thymic precursor cells in health and disease. I. Characterization of the autologous rosette-forming T cells as post-thymic precursors.
Palacios R; Alarcón-Segovia D; Llorente L; Ruíz-Arguelles A; Díaz-Jouanen E
Immunology; 1981 Jan; 42(1):127-35. PubMed ID: 6970170
[TBL] [Abstract][Full Text] [Related]
33. Effect of levamisole on E-rosette-forming cells in vivo and in vitro in Hodgkin's disease.
Ramot B; Biniaminov M; Shoham C; Rosenthal E
N Engl J Med; 1976 Apr; 294(15):809-11. PubMed ID: 1082545
[TBL] [Abstract][Full Text] [Related]
34. Surface markers of blood lymphocytes in bronchial carcinoma.
Bodolay E; Szabó G; Juhász I; Komoróczy Z; Diczházy A
Acta Med Hung; 1984; 41(2-3):121-7. PubMed ID: 6611544
[TBL] [Abstract][Full Text] [Related]
35. B and T lymphocytes in Hodgkin's disease. Analysis at diagnosis and following therapy.
Gajl-Peczalska KJ; Bloomfield CD; Sosin H; Kersey JH
Clin Exp Immunol; 1976 Jan; 23(1):47-55. PubMed ID: 1083318
[TBL] [Abstract][Full Text] [Related]
36. Ferritin-bearing lymphocytes in Hodgkin's disease.
Koprivová H; Hermanská Z; Novák F; Blehová Z; Dienstbier Z
Neoplasma; 1986; 33(1):63-9. PubMed ID: 3515213
[TBL] [Abstract][Full Text] [Related]
37. [Lymphocytes subpopulation in cancer's patients. Relationship with primitive anatomical location, histological type and clinical stage (author's transl)].
Saiz Garcia F; Rodriguez Valverde V
Bull Cancer; 1981; 68(1):32-9. PubMed ID: 6971668
[TBL] [Abstract][Full Text] [Related]
38. Reversal of cell surface abnormalities of T lymphocytes in hodgkin's disease after in vitro incubation in fetal sera.
Fuks Z; Strober S; King DP; Kaplan HS
J Immunol; 1976 Oct; 117(4):1331-5. PubMed ID: 1086325
[TBL] [Abstract][Full Text] [Related]
39. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
[TBL] [Abstract][Full Text] [Related]
40. [T lymphocytes from patients with Hodgkin's disease suppress erythroid progenitor growth from autologous marrow].
Hansz J; Kozłowska-Skrzypczak M; Sawiński K; Włodarczyk M
Acta Haematol Pol; 1995; 26(2):185-93. PubMed ID: 7653224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
